25 XP   0   0   10

China Grand Pharmaceutical and Healthcare Holdings Ltd
Buy, Hold or Sell?

Let's analyse China Grand Pharmaceutical and Healthcare Holdings Ltd together

PenkeI guess you are interested in China Grand Pharmaceutical and Healthcare Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Grand Pharmaceutical and Healthcare Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China Grand Pharmaceutical and Healthcare Holdings Ltd

I send you an email if I find something interesting about China Grand Pharmaceutical and Healthcare Holdings Ltd.

Quick analysis of China Grand Pharmaceutical and Healthcare Holdings Ltd (30 sec.)










What can you expect buying and holding a share of China Grand Pharmaceutical and Healthcare Holdings Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.06
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
HK$3.98
Expected worth in 1 year
HK$4.83
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
HK$1.28
Return On Investment
30.1%

For what price can you sell your share?

Current Price per Share
HK$4.26
Expected price per share
HK$3.77 - HK$4.69
How sure are you?
50%

1. Valuation of China Grand Pharmaceutical and Healthcare Holdings Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$4.26

Intrinsic Value Per Share

HK$1.39 - HK$4.33

Total Value Per Share

HK$5.37 - HK$8.31

2. Growth of China Grand Pharmaceutical and Healthcare Holdings Ltd (5 min.)




Is China Grand Pharmaceutical and Healthcare Holdings Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.8b$1.7b$95.4m5.3%

How much money is China Grand Pharmaceutical and Healthcare Holdings Ltd making?

Current yearPrevious yearGrowGrow %
Making money$265.5m$306.8m-$41.2m-15.5%
Net Profit Margin21.7%27.9%--

How much money comes from the company's main activities?

3. Financial Health of China Grand Pharmaceutical and Healthcare Holdings Ltd (5 min.)




What can you expect buying and holding a share of China Grand Pharmaceutical and Healthcare Holdings Ltd? (5 min.)

Welcome investor! China Grand Pharmaceutical and Healthcare Holdings Ltd's management wants to use your money to grow the business. In return you get a share of China Grand Pharmaceutical and Healthcare Holdings Ltd.

What can you expect buying and holding a share of China Grand Pharmaceutical and Healthcare Holdings Ltd?

First you should know what it really means to hold a share of China Grand Pharmaceutical and Healthcare Holdings Ltd. And how you can make/lose money.

Speculation

The Price per Share of China Grand Pharmaceutical and Healthcare Holdings Ltd is HK$4.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Grand Pharmaceutical and Healthcare Holdings Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Grand Pharmaceutical and Healthcare Holdings Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$3.98. Based on the TTM, the Book Value Change Per Share is HK$0.21 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.58 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Grand Pharmaceutical and Healthcare Holdings Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.071.8%0.071.8%0.092.0%0.061.4%0.030.8%
Usd Book Value Change Per Share0.030.6%0.030.6%0.071.7%0.082.0%0.051.1%
Usd Dividend Per Share0.010.3%0.010.3%0.010.3%0.010.3%0.010.2%
Usd Total Gains Per Share0.041.0%0.041.0%0.092.1%0.102.3%0.051.3%
Usd Price Per Share0.59-0.59-0.82-0.66-0.45-
Price to Earnings Ratio7.85-7.85-9.54-12.30-20.47-
Price-to-Total Gains Ratio14.35-14.35-9.40-9.00-17.68-
Price to Book Ratio1.15-1.15-1.71-1.69-2.78-
Price-to-Total Gains Ratio14.35-14.35-9.40-9.00-17.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.544002
Number of shares1838
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.030.08
Usd Total Gains Per Share0.040.10
Gains per Quarter (1838 shares)75.26176.44
Gains per Year (1838 shares)301.04705.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
110319829190616696
220739659217912321402
331059389326918482108
4413791119435824652814
5516989149544830813520
66201187179653836974226
77231384209762743134932
88261582239871749295638
99291780269980755456344
1010331978300089661617050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.05.04.060.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.07.00.069.6%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.04.060.0%8.00.015.034.8%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.07.00.069.6%

Fundamentals of China Grand Pharmaceutical and Healthcare Holdings Ltd

About China Grand Pharmaceutical and Healthcare Holdings Ltd

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It also manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.

Fundamental data was last updated by Penke on 2024-04-15 08:24:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of China Grand Pharmaceutical and Healthcare Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China Grand Pharmaceutical and Healthcare Holdings Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 21.7% means that $0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 21.7%. The company is making a huge profit. +2
  • The TTM is 21.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.7%TTM21.7%0.0%
TTM21.7%YOY27.9%-6.2%
TTM21.7%5Y21.5%+0.3%
5Y21.5%10Y13.9%+7.5%
1.1.2. Return on Assets

Shows how efficient China Grand Pharmaceutical and Healthcare Holdings Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.3% Return on Assets means that China Grand Pharmaceutical and Healthcare Holdings Ltd generated $0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 9.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM9.3%0.0%
TTM9.3%YOY11.4%-2.1%
TTM9.3%5Y9.0%+0.3%
5Y9.0%10Y6.3%+2.7%
1.1.3. Return on Equity

Shows how efficient China Grand Pharmaceutical and Healthcare Holdings Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.7% Return on Equity means China Grand Pharmaceutical and Healthcare Holdings Ltd generated $0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 14.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.7%TTM14.7%0.0%
TTM14.7%YOY17.9%-3.2%
TTM14.7%5Y14.4%+0.3%
5Y14.4%10Y15.1%-0.7%

1.2. Operating Efficiency of China Grand Pharmaceutical and Healthcare Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China Grand Pharmaceutical and Healthcare Holdings Ltd is operating .

  • Measures how much profit China Grand Pharmaceutical and Healthcare Holdings Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY25.4%-25.4%
TTM-5Y18.3%-18.3%
5Y18.3%10Y14.2%+4.1%
1.2.2. Operating Ratio

Measures how efficient China Grand Pharmaceutical and Healthcare Holdings Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are $1.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 1.097. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.097. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.097TTM1.0970.000
TTM1.097YOY1.164-0.067
TTM1.0975Y1.164-0.067
5Y1.16410Y1.317-0.153

1.3. Liquidity of China Grand Pharmaceutical and Healthcare Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China Grand Pharmaceutical and Healthcare Holdings Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.07 means the company has $1.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 1.067. The company is just able to pay all its short-term debts.
  • The TTM is 1.067. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.067TTM1.0670.000
TTM1.067YOY1.218-0.151
TTM1.0675Y1.055+0.012
5Y1.05510Y0.919+0.136
1.3.2. Quick Ratio

Measures if China Grand Pharmaceutical and Healthcare Holdings Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.71 means the company can pay off $0.71 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 0.715. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.715. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.715TTM0.7150.000
TTM0.715YOY0.889-0.174
TTM0.7155Y0.783-0.068
5Y0.78310Y0.617+0.167

1.4. Solvency of China Grand Pharmaceutical and Healthcare Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China Grand Pharmaceutical and Healthcare Holdings Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.37 means that China Grand Pharmaceutical and Healthcare Holdings Ltd assets are financed with 36.8% credit (debt) and the remaining percentage (100% - 36.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 0.368. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.368. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.368TTM0.3680.000
TTM0.368YOY0.364+0.004
TTM0.3685Y0.379-0.011
5Y0.37910Y0.560-0.181
1.4.2. Debt to Equity Ratio

Measures if China Grand Pharmaceutical and Healthcare Holdings Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 58.2% means that company has $0.58 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The MRQ is 0.582. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.582. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.582TTM0.5820.000
TTM0.582YOY0.572+0.010
TTM0.5825Y0.626-0.044
5Y0.62610Y2.045-1.419

2. Market Valuation of China Grand Pharmaceutical and Healthcare Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings China Grand Pharmaceutical and Healthcare Holdings Ltd generates.

  • Above 15 is considered overpriced but always compare China Grand Pharmaceutical and Healthcare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 7.85 means the investor is paying $7.85 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The EOD is 7.272. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.852. Based on the earnings, the company is underpriced. +1
  • The TTM is 7.852. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD7.272MRQ7.852-0.580
MRQ7.852TTM7.8520.000
TTM7.852YOY9.544-1.692
TTM7.8525Y12.302-4.450
5Y12.30210Y20.475-8.173
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The EOD is 19.959. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.552. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 21.552. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD19.959MRQ21.552-1.593
MRQ21.552TTM21.5520.000
TTM21.552YOY15.606+5.946
TTM21.5525Y18.227+3.325
5Y18.22710Y55.004-36.777
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China Grand Pharmaceutical and Healthcare Holdings Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of China Grand Pharmaceutical and Healthcare Holdings Ltd:

  • The EOD is 1.069. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.155. Based on the equity, the company is underpriced. +1
  • The TTM is 1.155. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.069MRQ1.155-0.085
MRQ1.155TTM1.1550.000
TTM1.155YOY1.712-0.557
TTM1.1555Y1.690-0.535
5Y1.69010Y2.785-1.095
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China Grand Pharmaceutical and Healthcare Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2110.2110%0.577-63%0.656-68%0.373-44%
Book Value Per Share--3.9843.9840%3.773+6%3.101+28%1.786+123%
Current Ratio--1.0671.0670%1.218-12%1.055+1%0.919+16%
Debt To Asset Ratio--0.3680.3680%0.364+1%0.379-3%0.560-34%
Debt To Equity Ratio--0.5820.5820%0.572+2%0.626-7%2.045-72%
Dividend Per Share--0.1100.1100%0.1100%0.095+15%0.056+96%
Eps--0.5860.5860%0.677-13%0.460+27%0.264+122%
Free Cash Flow Per Share--0.2130.2130%0.414-48%0.291-27%0.168+27%
Free Cash Flow To Equity Per Share--0.3060.3060%0.320-5%0.463-34%0.287+6%
Gross Profit Margin--1.0001.0000%1.0000%-0.091+109%-1.328+233%
Intrinsic Value_10Y_max--4.329--------
Intrinsic Value_10Y_min--1.390--------
Intrinsic Value_1Y_max--0.345--------
Intrinsic Value_1Y_min--0.163--------
Intrinsic Value_3Y_max--1.104--------
Intrinsic Value_3Y_min--0.471--------
Intrinsic Value_5Y_max--1.945--------
Intrinsic Value_5Y_min--0.759--------
Market Cap14917710259.200-9%16328026600.00016328026600.0000%22930228660.000-29%18212691462.880-10%12436566965.360+31%
Net Profit Margin--0.2170.2170%0.279-22%0.215+1%0.139+56%
Operating Margin----0%0.254-100%0.183-100%0.142-100%
Operating Ratio--1.0971.0970%1.164-6%1.164-6%1.317-17%
Pb Ratio1.069-8%1.1551.1550%1.712-33%1.690-32%2.785-59%
Pe Ratio7.272-8%7.8527.8520%9.544-18%12.302-36%20.475-62%
Price Per Share4.260-8%4.6004.6000%6.460-29%5.152-11%3.527+30%
Price To Free Cash Flow Ratio19.959-8%21.55221.5520%15.606+38%18.227+18%55.004-61%
Price To Total Gains Ratio13.286-8%14.34614.3460%9.402+53%9.004+59%17.677-19%
Quick Ratio--0.7150.7150%0.889-20%0.783-9%0.617+16%
Return On Assets--0.0930.0930%0.114-19%0.090+4%0.063+48%
Return On Equity--0.1470.1470%0.179-18%0.144+2%0.151-3%
Total Gains Per Share--0.3210.3210%0.687-53%0.752-57%0.429-25%
Usd Book Value--1805721162.6001805721162.6000%1710238978.700+6%1400174618.480+29%805301676.150+124%
Usd Book Value Change Per Share--0.0270.0270%0.074-63%0.084-68%0.048-44%
Usd Book Value Per Share--0.5090.5090%0.482+6%0.396+28%0.228+123%
Usd Dividend Per Share--0.0140.0140%0.0140%0.012+15%0.007+96%
Usd Eps--0.0750.0750%0.086-13%0.059+27%0.034+122%
Usd Free Cash Flow--96746030.80096746030.8000%187630631.600-48%131270492.000-26%75858882.460+28%
Usd Free Cash Flow Per Share--0.0270.0270%0.053-48%0.037-27%0.021+27%
Usd Free Cash Flow To Equity Per Share--0.0390.0390%0.041-5%0.059-34%0.037+6%
Usd Market Cap1904991600.100-9%2085088996.8202085088996.8200%2928190199.882-29%2325760699.810-10%1588149601.476+31%
Usd Price Per Share0.544-8%0.5870.5870%0.825-29%0.658-11%0.450+30%
Usd Profit--265541806.300265541806.3000%306807295.100-13%207851109.320+28%119067275.680+123%
Usd Revenue--1221103794.5001221103794.5000%1097961407.500+11%946567796.260+29%696668971.790+75%
Usd Total Gains Per Share--0.0410.0410%0.088-53%0.096-57%0.055-25%
 EOD+4 -4MRQTTM+0 -0YOY+9 -245Y+21 -1510Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of China Grand Pharmaceutical and Healthcare Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.272
Price to Book Ratio (EOD)Between0-11.069
Net Profit Margin (MRQ)Greater than00.217
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.715
Current Ratio (MRQ)Greater than11.067
Debt to Asset Ratio (MRQ)Less than10.368
Debt to Equity Ratio (MRQ)Less than10.582
Return on Equity (MRQ)Greater than0.150.147
Return on Assets (MRQ)Greater than0.050.093
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of China Grand Pharmaceutical and Healthcare Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.211
Ma 20Greater thanMa 504.047
Ma 50Greater thanMa 1003.782
Ma 100Greater thanMa 2003.812
OpenGreater thanClose4.040
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets22,371,061
Total Liabilities8,230,723
Total Stockholder Equity14,140,338
 As reported
Total Liabilities 8,230,723
Total Stockholder Equity+ 14,140,338
Total Assets = 22,371,061

Assets

Total Assets22,371,061
Total Current Assets6,886,920
Long-term Assets15,484,141
Total Current Assets
Cash And Cash Equivalents 1,444,014
Short-term Investments 1,038,582
Net Receivables 1,093,854
Inventory 1,340,466
Other Current Assets 856,942
Total Current Assets  (as reported)6,886,920
Total Current Assets  (calculated)5,773,858
+/- 1,113,062
Long-term Assets
Property Plant Equipment 3,562,252
Goodwill 644,047
Intangible Assets 1,397,992
Other Assets 1,053,607
Long-term Assets  (as reported)15,484,141
Long-term Assets  (calculated)6,657,898
+/- 8,826,243

Liabilities & Shareholders' Equity

Total Current Liabilities6,454,601
Long-term Liabilities1,707,800
Total Stockholder Equity14,140,338
Total Current Liabilities
Short Long Term Debt 3,243,126
Accounts payable 872,860
Total Current Liabilities  (as reported)6,454,601
Total Current Liabilities  (calculated)4,115,986
+/- 2,338,615
Long-term Liabilities
Long term Debt Total 1,222,371
Capital Lease Obligations Min Short Term Debt69,868
Long-term Liabilities  (as reported)1,707,800
Long-term Liabilities  (calculated)1,292,239
+/- 415,561
Total Stockholder Equity
Common Stock35,496
Retained Earnings 8,223,556
Capital Surplus 6,523,049
Other Stockholders Equity -355,303
Total Stockholder Equity (as reported)14,140,338
Total Stockholder Equity (calculated)14,426,798
+/- 286,460
Other
Capital Stock35,496
Cash And Equivalents1,444,014
Cash and Short Term Investments 2,482,596
Common Stock Shares Outstanding 3,549,571
Liabilities and Stockholders Equity 22,371,061
Net Debt 2,961,400
Net Invested Capital 18,545,752
Net Working Capital 432,319
Property Plant and Equipment Gross 5,558,604



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
543,344
377,088
393,877
413,614
269,265
197,400
219,876
198,699
569,891
608,701
1,687,086
2,431,147
3,354,085
4,565,349
4,990,681
6,633,385
7,141,947
8,062,791
13,496,659
13,813,307
16,984,345
21,057,030
22,371,061
22,371,06121,057,03016,984,34513,813,30713,496,6598,062,7917,141,9476,633,3854,990,6814,565,3493,354,0852,431,1471,687,086608,701569,891198,699219,876197,400269,265413,614393,877377,088543,344
   > Total Current Assets 
0
0
0
0
102,887
67,803
95,851
83,787
176,661
207,300
828,941
1,087,425
1,239,579
1,871,743
2,133,234
2,405,891
2,481,093
2,947,431
3,429,052
3,816,323
5,318,958
6,778,589
6,886,920
6,886,9206,778,5895,318,9583,816,3233,429,0522,947,4312,481,0932,405,8912,133,2341,871,7431,239,5791,087,425828,941207,300176,66183,78795,85167,803102,8870000
       Cash And Cash Equivalents 
45,326
90,562
63,182
42,670
56,272
47,650
59,407
67,282
42,501
60,227
306,999
343,348
304,588
249,765
460,401
653,987
484,418
640,842
912,244
1,059,269
1,836,695
1,752,860
1,444,014
1,444,0141,752,8601,836,6951,059,269912,244640,842484,418653,987460,401249,765304,588343,348306,99960,22742,50167,28259,40747,65056,27242,67063,18290,56245,326
       Short-term Investments 
20,611
16,512
17,353
20,723
7,314
7,933
10,519
1,873
0
5,006
52,692
66,939
23,816
129,023
50,000
1,201
11,206
18,011
45,605
71,891
520,767
1,112,968
1,038,582
1,038,5821,112,968520,76771,89145,60518,01111,2061,20150,000129,02323,81666,93952,6925,00601,87310,5197,9337,31420,72317,35316,51220,611
       Net Receivables 
121,304
35,448
16,737
16,947
8,469
7,773
8,109
6,435
64,821
85,696
246,405
348,672
458,362
925,911
1,005,499
465,703
1,168,338
1,347,684
1,361,646
1,554,744
1,716,115
967,703
1,093,854
1,093,854967,7031,716,1151,554,7441,361,6461,347,6841,168,338465,7031,005,499925,911458,362348,672246,40585,69664,8216,4358,1097,7738,46916,94716,73735,448121,304
       Inventory 
16,384
10,961
8,370
5,062
3,583
4,447
4,077
8,078
64,295
54,968
216,168
319,163
442,297
562,283
516,565
621,702
636,226
762,933
770,329
814,373
955,314
1,117,156
1,340,466
1,340,4661,117,156955,314814,373770,329762,933636,226621,702516,565562,283442,297319,163216,16854,96864,2958,0784,0774,4473,5835,0628,37010,96116,384
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,660,854
5,115,360
10,067,607
9,996,984
11,665,387
14,278,441
15,484,141
15,484,14114,278,44111,665,3879,996,98410,067,6075,115,3604,660,8540000000000000000
       Property Plant Equipment 
285,041
192,296
196,997
153,770
88,602
37,732
36,847
110,572
333,704
334,476
450,918
726,068
1,423,363
2,095,369
2,291,205
2,543,235
2,643,606
2,891,785
2,876,443
2,936,566
3,052,945
3,426,192
3,562,252
3,562,2523,426,1923,052,9452,936,5662,876,4432,891,7852,643,6062,543,2352,291,2052,095,3691,423,363726,068450,918334,476333,704110,57236,84737,73288,602153,770196,997192,296285,041
       Goodwill 
0
0
0
0
0
2,450
1,050
0
0
0
54,944
72,037
97,133
124,777
124,682
380,589
481,075
511,539
487,848
480,321
505,574
596,746
644,047
644,047596,746505,574480,321487,848511,539481,075380,589124,682124,77797,13372,03754,9440001,0502,45000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
49,684
46,176
321,852
325,718
374,420
5,406,515
0
0
0
0
00005,406,515374,420325,718321,85246,17649,6840000000000000
       Intangible Assets 
0
0
54,637
130,400
70,855
13,300
11,600
0
1,579
1,252
958
649
298
82,782
68,454
651,305
796,418
875,718
815,998
1,121,991
881,843
1,009,764
1,397,992
1,397,9921,009,764881,8431,121,991815,998875,718796,418651,30568,45482,7822986499581,2521,579011,60013,30070,855130,40054,63700
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
74,680
27,804
13,969
5,018
7,592
38,874
41,653
10,067,607
9,996,984
0
0
0
0009,996,98410,067,60741,65338,8747,5925,01813,96927,80474,68000000000000
> Total Liabilities 
178,980
175,748
178,653
239,939
217,559
174,695
207,956
240,542
480,933
479,478
840,237
1,461,228
2,474,356
3,474,560
3,682,314
5,229,046
5,165,860
5,603,190
6,062,032
5,302,300
5,640,136
7,664,399
8,230,723
8,230,7237,664,3995,640,1365,302,3006,062,0325,603,1905,165,8605,229,0463,682,3143,474,5602,474,3561,461,228840,237479,478480,933240,542207,956174,695217,559239,939178,653175,748178,980
   > Total Current Liabilities 
178,980
175,748
153,573
160,921
217,559
172,245
130,922
159,245
221,631
264,450
636,507
1,030,797
1,956,654
2,614,229
2,272,806
3,248,759
3,157,323
4,006,765
4,966,848
3,589,563
4,302,927
5,566,125
6,454,601
6,454,6015,566,1254,302,9273,589,5634,966,8484,006,7653,157,3233,248,7592,272,8062,614,2291,956,6541,030,797636,507264,450221,631159,245130,922172,245217,559160,921153,573175,748178,980
       Short-term Debt 
0
0
0
0
76,303
43,462
54,022
106,730
77,273
118,465
306,717
695,231
1,305,755
1,262,267
1,096,041
1,962,484
1,663,874
2,165,957
2,252,077
967,607
1,568,454
0
0
001,568,454967,6072,252,0772,165,9571,663,8741,962,4841,096,0411,262,2671,305,755695,231306,717118,46577,273106,73054,02243,46276,3030000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,692,868
1,083,584
1,962,484
1,663,874
2,165,957
2,252,077
967,607
1,568,454
2,116,471
3,243,126
3,243,1262,116,4711,568,454967,6072,252,0772,165,9571,663,8741,962,4841,083,5841,692,8680000000000000
       Accounts payable 
16,735
12,259
8,272
3,869
3,186
3,059
3,108
2,846
41,367
63,351
136,030
145,160
304,642
707,794
655,330
652,943
723,477
646,520
1,066,405
867,448
720,063
734,498
872,860
872,860734,498720,063867,4481,066,405646,520723,477652,943655,330707,794304,642145,160136,03063,35141,3672,8463,1083,0593,1863,8698,27212,25916,735
       Other Current Liabilities 
108,313
111,914
95,702
96,894
93,070
115,661
51,395
49,669
102,991
82,634
193,760
190,406
346,257
638,652
515,702
130,570
137,527
173,323
640,635
536,582
528,915
556,655
0
0556,655528,915536,582640,635173,323137,527130,570515,702638,652346,257190,406193,76082,634102,99149,66951,395115,66193,07096,89495,702111,914108,313
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,008,537
1,596,425
1,095,184
1,712,737
1,337,209
2,048,043
1,707,800
1,707,8002,048,0431,337,2091,712,7371,095,1841,596,4252,008,5370000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,179,009
1,210,708
768,590
320,278
1,074,618
813,724
1,523,376
1,222,371
1,222,3711,523,376813,7241,074,618320,278768,5901,210,7081,179,009000000000000000
       Other Liabilities 
0
0
22,894
1,018
0
0
74,829
67,889
0
0
83,529
298,125
301,012
385,046
661,014
778,221
774,582
827,835
774,906
638,119
523,485
524,667
0
0524,667523,485638,119774,906827,835774,582778,221661,014385,046301,012298,12583,5290067,88974,829001,01822,89400
> Total Stockholder Equity
344,267
188,528
186,195
142,474
39,651
19,303
9,091
0
4,608
32,952
567,786
639,178
753,274
876,883
1,113,411
1,159,668
1,702,434
2,233,886
7,190,959
8,375,267
11,239,504
13,392,631
14,140,338
14,140,33813,392,63111,239,5048,375,2677,190,9592,233,8861,702,4341,159,6681,113,411876,883753,274639,178567,78632,9524,60809,09119,30339,651142,474186,195188,528344,267
   Common Stock
81,510
81,510
97,810
138,143
3,580
10,739
10,739
10,739
10,739
10,739
19,208
19,208
19,620
19,620
19,620
19,620
22,370
22,370
31,348
33,776
35,496
35,496
35,496
35,49635,49635,49633,77631,34822,37022,37019,62019,62019,62019,62019,20819,20810,73910,73910,73910,73910,7393,580138,14397,81081,51081,510
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 000-1,336,209-932,414-794,306-542,000-400,711-240,503-161,374-149,594-86,739-47,1370-6,09300000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
281,949
660,537
660,537
5,052,102
5,511,107
6,523,049
6,523,049
6,523,049
6,523,0496,523,0496,523,0495,511,1075,052,102660,537660,537281,949000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
99,647
160,967
70,778
-81,397
-10,756
-167,758
-305,360
11,204,008
361,316
-355,303
-355,303361,31611,204,008-305,360-167,758-10,756-81,39770,778160,96799,6470000000000000



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in HKD. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue9,562,285
Cost of Revenue-3,610,806
Gross Profit5,951,4795,951,479
 
Operating Income (+$)
Gross Profit5,951,479
Operating Expense-6,877,189
Operating Income2,698,172-925,710
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,373,534
Selling And Marketing Expenses0
Operating Expense6,877,1893,373,534
 
Net Interest Income (+$)
Interest Income181,279
Interest Expense-13,746
Other Finance Cost-285,220
Net Interest Income-117,687
 
Pretax Income (+$)
Operating Income2,698,172
Net Interest Income-117,687
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,516,8932,698,172
EBIT - interestExpense = -13,746
2,079,419
2,093,165
Interest Expense13,746
Earnings Before Interest and Taxes (EBIT)02,530,639
Earnings Before Interest and Taxes (EBITDA)3,049,298
 
After tax Income (+$)
Income Before Tax2,516,893
Tax Provision-418,642
Net Income From Continuing Ops2,098,2512,098,251
Net Income2,079,419
Net Income Applicable To Common Shares2,079,419
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0117,687
 

Technical Analysis of China Grand Pharmaceutical and Healthcare Holdings Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Grand Pharmaceutical and Healthcare Holdings Ltd. The general trend of China Grand Pharmaceutical and Healthcare Holdings Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Grand Pharmaceutical and Healthcare Holdings Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Grand Pharmaceutical and Healthcare Holdings Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.29 < 4.3 < 4.69.

The bearish price targets are: 4.17 > 3.83 > 3.77.

Tweet this
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current macd is 0.07529542.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the China Grand Pharmaceutical and Healthcare Holdings Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for China Grand Pharmaceutical and Healthcare Holdings Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the China Grand Pharmaceutical and Healthcare Holdings Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current adx is 24.98.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy China Grand Pharmaceutical and Healthcare Holdings Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current sar is 3.83.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current rsi is 66.21. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Relative Strength Index (RSI) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Grand Pharmaceutical and Healthcare Holdings Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Stochastic Oscillator ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current cci is 133.45.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Commodity Channel Index (CCI) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current cmo is 43.69.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current willr is -9.09090909.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Williams %R ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Grand Pharmaceutical and Healthcare Holdings Ltd.

China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current atr is 0.14077038.

China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Average True Range (ATR) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current obv is 129,719,197.

China Grand Pharmaceutical and Healthcare Holdings Ltd Daily On-Balance Volume (OBV) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Grand Pharmaceutical and Healthcare Holdings Ltd. The current mfi is 65.84.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Money Flow Index (MFI) ChartChina Grand Pharmaceutical and Healthcare Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Grand Pharmaceutical and Healthcare Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

China Grand Pharmaceutical and Healthcare Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Grand Pharmaceutical and Healthcare Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.211
Ma 20Greater thanMa 504.047
Ma 50Greater thanMa 1003.782
Ma 100Greater thanMa 2003.812
OpenGreater thanClose4.040
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China Grand Pharmaceutical and Healthcare Holdings Ltd with someone you think should read this too:
  • Are you bullish or bearish on China Grand Pharmaceutical and Healthcare Holdings Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Grand Pharmaceutical and Healthcare Holdings Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Grand Pharmaceutical and Healthcare Holdings Ltd

I send you an email if I find something interesting about China Grand Pharmaceutical and Healthcare Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China Grand Pharmaceutical and Healthcare Holdings Ltd.

Receive notifications about China Grand Pharmaceutical and Healthcare Holdings Ltd in your mailbox!